4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Nadiifinta ≥99.5% (GC) Warshada iibka kulul
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Magaca Kiimikada | 4,6-Dichloro-2-Methylpyrimidine |
La mid ah | 2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine |
Lambarka CAS | 1780-26-3 |
Lambarka CAT | RF-PI687 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C5H4Cl2N2 |
Miisaanka Molecular | 163.00 |
Meesha dhalaalaysa | 41.5 ~ 45.5 ℃ (Iftiin) |
Solubility (Ku milma) | Methanol |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Caddaan ama Banaan-cad budada Crystalline |
Daahirnimada / Habka Falanqaynta | ≥99.5% (GC) |
Khasaare xagga qalajinta | ≤0.50% |
Hadhaaga dabka | ≤0.20% |
Xumaanta Keliya | ≤0.50% |
Wadarta wasakhda | ≤0.50% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Dawada;Dasatinib/Moxonidine Dhexdhexaadiye |
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Habka Habka
Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) waxaa loo isticmaalaa isku dhafka dhexdhexaadiyeyaasha dawooyinka iyo API-yada.Alaabta Diyaarinta: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydrate (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).Moxonidine waa nooc cusub oo ah daawada dhiig-karka, oo caadi ahaan loo isticmaalo daawaynta dhiig-karka muhiimka ah.Marka la barbar dhigo daawooyinkii hore ee ka-hortagga hypertensive dhexe, Moxonidine waxay ku xidhan tahay xidhiidh aad u weyn oo ay la leedahay imidazoline I1-receptor marka loo eego α2-receptor.Dasatinib waa awood afka laga qaato oncogenic kinase inhibitor, kaas oo xannibi kara calaamadaha dardargelinta taranka unugyada kansarka, bishii Maajo 2009, Maamulka Cuntada iyo Dawooyinka ee Mareykanka (FDA) ayaa si rasmi ah u ansixiyay iibinta dasatinib myeloid leukemia (CML), oo ay ku jiraan daaweynta myeloid leukemia raaga oo u adkaysata ama aan u dulqaadan karin barnaamijyada daawaynta oo ay ku jiraan imatinib mesylate., Philadelphia chromosome-positive lymphoblastic leukemia (Ph + ALL) iyo daaweynta bukaanada qaba burooyinka adag.